Ubrogepant, approved for acute treatment of migraine, may also reduce nonheadache symptoms that occur in the hours preceding ...

There’s a lot gone on since [the last guideline was published in] 2014, and it now doesn’t reflect best practice,’ said ...

Patients on SGLT2 inhibitors have a reduced risk for acute kidney injury following surgery but have a modestly increased risk ...

A 60-year-old woman presents with refractory hypertension and psychosis, revealing a rare adrenal cortical carcinoma — an ...

Records from more than 4800 ophthalmology residents show the average number of cataract surgeries and other eye procedures ...

Interim surveillance network data showed lower hospitalization rates following the availability of prevention products.

We share six evidence-based apps that can help medical students learn to diagnose illnesses, prescribe medications, and stay ...

Gynecologic surgeons are urging Congress to fix a pay system they say hurts women. But the AMA and ACOG are pushing back, ...

From genetic risks to inflammation markers, uncover the latest insights in cardiovascular prevention that every primary care ...

Long-term results of a phase 3 trial show that early rituximab monotherapy significantly delays the need for new treatment in ...

Phase 3 results show the investigational drug norucholic acid is superior to placebo in halting disease progression.

The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...